Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPAVAC: HPV Vaccines in HIV Infected Adults
NCT01386164Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of qHPV vaccine, human papillomavirus type 16 L1 capsid protein antigen in human papillomavirus infection, sponsored by Aarhus University. Started Aug 2011; status: completed.
02
Drugs
qHPV vaccinehuman papillomavirus type 16 L1 capsid protein antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01386164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386164.